148 related articles for article (PubMed ID: 38019697)
1. The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
Ouedraogo S; Traoré IT; Kania D; Kaboré NF; Mamguem Kamga A; Badolo H; Yara M; Sanou G; Koné A; Kagoné ST; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendere AE; Ouédraogo B; Billa O; Paradis G; Tinto H; Dabakuyo-Yonli TS
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13216. PubMed ID: 38019697
[TBL] [Abstract][Full Text] [Related]
2. Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
Kaboré NF; Ouédraogo S; Mamguem AK; Traoré IT; Kania D; Badolo H; Sanou G; Koné A; Yara M; Kagoné T; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendéré AE; Ouédraogo B; Billa O; Paradis G; Dabakuyo-Yonli TS; Tinto H
BMC Infect Dis; 2023 Jun; 23(1):394. PubMed ID: 37308819
[TBL] [Abstract][Full Text] [Related]
3. High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study.
Struck NS; Lorenz E; Deschermeier C; Eibach D; Kettenbeil J; Loag W; Brieger SA; Ginsbach AM; Obirikorang C; Maiga-Ascofare O; Sarkodie YA; Boham EEA; Adu EA; Asare G; Amoako-Adusei A; Yawson A; Boakye AO; Deke J; Almoustapha NS; Adu-Amoah L; Duah IK; Ouedraogo TA; Boudo V; Rushton B; Ehmen C; Fusco D; Gunga L; Benke D; Höppner Y; Rasolojaona ZT; Rasamoelina T; Rakotoarivelo RA; Rakotozandrindrainy R; Coulibaly B; Sié A; Awuah AA; Amuasi JH; Souares A; May J
BMC Public Health; 2022 Sep; 22(1):1676. PubMed ID: 36064368
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.
Traoré IT; Ouedraogo S; Kania D; Kaboré FN; Konaté B; Médah R; Badolo H; de Rekeneire N; Kamga AM; Poda A; Diendere AE; Ouédraogo B; Ouédraogo E; Billa O; Tinto H; Dabakuyo-Yonli TS
BMC Infect Dis; 2021 Sep; 21(1):896. PubMed ID: 34479501
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
Kaboré OD; Poda A; Ouattara CA; Michodigni FN; Belem AA; Sawadogo Y; Zoungrana J; Galal L; Meda CZ; Godreuil S; Ouédraogo AS
PLoS One; 2023; 18(6):e0286665. PubMed ID: 37315090
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 and co-infection with malaria during the first wave of the pandemic (the Burkina Faso case).
López-Farfán D; Yerbanga RS; Parres-Mercader M; Torres-Puente M; Gómez-Navarro I; Sanou DMS; Yao AF; Bosco Ouédraogo J; Comas I; Irigoyen N; Gómez-Díaz E
Front Public Health; 2022; 10():1048404. PubMed ID: 36579069
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of syphilis among men who have sex with men in Burkina Faso, West Africa.
Ouedraogo HG; Zida S; Compaore TR; Lanou BH; Rao A; Sagna T; Kadari C; Tarnagda G; Ky-Zerbo O; Traore Y; Baral S; Kouanda S; Barro N
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1803-1809. PubMed ID: 31201641
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 in urban settings in three sub-Saharan African countries (SeroCoV): a study protocol for a household-based cross-sectional prevalence study using two-stage cluster sampling.
Lorenz E; Souares A; Amuasi J; Loag W; Deschermeier C; Fusco D; Benke D; A Rakotoarivelo R; Rasamoelina MT; Rakotozandrindrainy R; Sie A; Afum-Adjei Awuah A; May J; Eibach D; Struck N
BMJ Open; 2021 Dec; 11(12):e056853. PubMed ID: 34921091
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa.
Ouedraogo HG; Zoure AA; Compaoré TR; Ky H; Zida S; Zingué D; Ouedraogo O; Soubeiga ST; Sagna T; Dabiré C; Kambiré D; Zongo D; Yonli AT; Nikiema AR; Nezien D; Bansé GC; Bicaba BW; Perier S; Sawadogo C; Yabre Z; Sangare L
Virol J; 2023 Mar; 20(1):57. PubMed ID: 36997951
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
Zamani M; Poustchi H; Mohammadi Z; Dalvand S; Sharafkhah M; Motevalian SA; Eslami S; Emami A; Somi MH; Yazdani-Charati J; Saki N; Karami M; Najafi F; Mohebbi I; Veisi N; Hormati A; Pourfarzi F; Ghadimi R; Ansari-Moghaddam A; Sharifi H; Roshandel G; Mansour-Ghanaei F; Joukar F; Shayanrad A; Eghtesad S; Niavarani A; Delavari A; Kaveh S; Feizesani A; Markarian M; Shafighian F; Sadjadi A; Darvishian M; Malekzadeh R
BMC Public Health; 2022 May; 22(1):1031. PubMed ID: 35606743
[TBL] [Abstract][Full Text] [Related]
13. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
14. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
16. Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.
Skrip L; Derra K; Kaboré M; Noori N; Gansané A; Valéa I; Tinto H; Brice BW; Gordon MV; Hagedorn B; Hien H; Althouse BM; Wenger EA; Ouédraogo AL
Int J Infect Dis; 2020 Dec; 101():194-200. PubMed ID: 32987177
[TBL] [Abstract][Full Text] [Related]
17. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.
Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadisa A; Admasu D; Tesfaye E; Bates TA; Bulcha JT; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
BMC Infect Dis; 2022 Mar; 22(1):261. PubMed ID: 35296265
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus (HIV) among men who have sex with men: results of the first integrated biological and behavioral survey in Burkina Faso, West Africa.
Ouedraogo HG; Ky-Zerbo O; Grosso A; Goodman S; Samadoulougou BC; Tarnagda G; Baguiya A; Tiendrebeogo S; Lougue M; Sawadogo N; Traore Y; Barro N; Baral S; Kouanda S
BMC Public Health; 2019 Jan; 19(1):5. PubMed ID: 30606172
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.
Gégout Petit A; Jeulin H; Legrand K; Jay N; Bochnakian A; Vallois P; Schvoerer E; Guillemin F
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
